ATRC - Company ID 0001323885
The table below shows AtriCure, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Revenue | $154.45M | $153.60M | $141.25M | $134.27M | $136.14M | $123.62M |
| Cost of revenue | $35.10M | $34.98M | $31.94M | $32.94M | $34.66M | $30.99M |
| Gross profit | $119.35M | $118.63M | $109.31M | $101.33M | $101.48M | $92.63M |
| R&D | $32.12M | $26.40M | $24.23M | $22.89M | $29.28M | $22.53M |
AtriCure, Inc. reported annual revenue of $534.53M for fiscal year 2025. That is up 14.9% from $465.31M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $155.11M (FY 2016) to $534.53M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $82.88M | $82.56M | $84.55M | $78.23M | $78.39M | $76.05M |
| Operating income | $4.35M | $9.66M | $526.00K | $208.00K | -$6.19M | -$5.95M |
| Income tax | -$47.00K | $471.00K | $286.00K | $181.00K | $261.00K | $239.00K |
| Net income | $4.06M | $8.96M | $108.00K | -$267.00K | -$6.19M | -$6.75M |
| EPS (diluted) | $0.08 | $0.18 | $0.00 | -$0.01 | -$0.13 | -$0.14 |